Japanese firm’s AI algorithm for gastric cancer gets FDA’s Breakthrough Device designation
Tokyo-based AI Medical Service won breakthrough device designation from the FDA for its technology that uses machine learning to identify gastric cancer... Read More
December 2019 Newsletter
Our Gastric Cancer Foundation Newsletter: December 2019 features a special message from Foundation Board Chair, Paul Gottsegen.
